Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-10-22 | Dr. Patti received a B.S. in Microbiology from the University of Pittsburgh, a M.S.P.H. from the University of Miami, School of Medicine and a Ph.D. in Biochemistry from the University of Alabama at Birmingham. |
| 2020-03-06 | Joseph M. Patti, Ph.D. (Director) |
| 2020-10-22 | Dr. Patti received a B.S. in Microbiology from the University of Pittsburgh, a M.S.P.H. from the University of Miami, School of Medicine and a Ph.D. in Biochemistry from the University of Alabama at Birmingham. He was selected as a director because of his scientific knowledge and background and experience in developing numerous preclinical and clinical bio-pharmaceutical product candidates. |
| 2021-02-26 | Joseph M. Patti, Ph.D. (Director) |
| 2021-04-21 | Joseph M. Patti, Ph.D. has served as a member of the Board of Directors since the consummation of the Merger in May 2019. He has scientific knowledge and background in developing bio-pharmaceutical product candidates and senior management experience in biotechnology companies. |
| 2022-03-09 | Dr. Patti is a director with a Ph.D., but no specific technical or software background is described. |
| 2022-10-17 | Dr. Patti received a B.S. in Microbiology from the University of Pittsburgh, a M.S.P.H. from the University of Miami, School of Medicine, and a Ph.D. in Biochemistry from the University of Alabama at Birmingham. |
| 2023-08-03 | Dr. Patti received a B.S. in Microbiology from the University of Pittsburgh, a M.S.P.H. from the University of Miami School of Medicine, and a Ph.D. in Biochemistry from the University of Alabama at Birmingham. |
| 2024-04-29 | Dr. Patti received a B.S. in Microbiology from the University of Pittsburgh, a M.S.P.H. from the University of Miami School of Medicine, and a Ph.D. in Biochemistry from the University of Alabama at Birmingham. |
| Filing Date | Source Excerpt |
|---|---|
| 2014-10-03 | Joseph M. Patti, Ph.D., age 50, joined the Company on November 12, 2012 and served as its Executive Vice President of Corporate Development and Strategy until October 1, 2014, when he was appointed as the Company’s President and Chief Executive Officer. |
| 2015-09-30 | Joseph M. Patti, Ph.D., age 51, joined the Company in November 2012 and served as its Executive Vice President of Corporate Development and Strategy until October 1, 2014, when he was appointed as the Company’s President and Chief Executive Officer and a director. |
| 2016-09-27 | Joseph M. Patti, Ph.D., age 52, joined the Company in November 2012 and served as its Executive Vice President of Corporate Development and Strategy until October 1, 2014, when he was appointed as the Company’s President and Chief Executive Officer and a director. ... Dr. Patti’s scientific knowledge and background and experience in developing numerous preclinical and clinical bio-pharmaceutical product candidates, as well as his senior management experience over the past decade in developing and implementing the business and financial strategies of emerging, publicly-traded biopharmaceutical companies, led to the conclusion that he should serve on the Company’s Board of Directors. |
Data sourced from SEC filings. Last updated: 2025-12-06